Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Segment Performance
BAX logo

Baxter Divests Kidney Care for $3.8 Billion to Fuel Deleveraging

BAX10-KFiling Date: 2/12/2026
Baxter International Inc.
Description

What this story covers

Baxter International is undergoing a major transformation, divesting its Kidney Care segment for $3.8 billion to reduce its $9.48 billion debt. Despite a $957 million net loss due to restructuring, operational sales grew 3% in 2025.

Story snapshot

CompanyBaxter International Inc.
TickerBAX
VariantStandard detailed
Duration12:28
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-007733
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in